Yu Xiong
Chief Executive Officer at UKDE Ltd.
Profile
Yu Xiong currently works at UKDE Ltd., as Co-Chairman & Chair-Management Board and 3D Bio-Tissues Ltd., as Director.
Yu Xiong active positions
Companies | Position | Start |
---|---|---|
3D Bio-Tissues Ltd.
3D Bio-Tissues Ltd. BiotechnologyHealth Technology Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million. | Director/Board Member | - |
UKDE Ltd.
UKDE Ltd. Packaged SoftwareTechnology Services UKDE Ltd. provides digital finance and blockchain technology services. The private company is based in London, UK. The British company was founded in 2018 by Guoyu Du. The CEO is Yu Xiong. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
UKDE Ltd.
UKDE Ltd. Packaged SoftwareTechnology Services UKDE Ltd. provides digital finance and blockchain technology services. The private company is based in London, UK. The British company was founded in 2018 by Guoyu Du. The CEO is Yu Xiong. | Technology Services |
3D Bio-Tissues Ltd.
3D Bio-Tissues Ltd. BiotechnologyHealth Technology Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million. | Health Technology |
- Stock Market
- Insiders
- Yu Xiong